- Issuer ticker
-
ICCC
- Reported as of
-
16 Apr 2025
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
14 Apr 2026, 15:37:12 UTC
Filing notes and source
Key filing fact
Bobbi Jo Brockmann filed Form 4 for IMMUCELL CORP /DE/ (ICCC) on 14 Apr 2026.
Key facts
- This page summarizes Bobbi Jo Brockmann's Form 4 filing for IMMUCELL CORP /DE/ (ICCC).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 14 Apr 2026, 15:37.
Change
- Previous filing in this sequence was filed on 09 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001517536
Primary reporting owner
Brockmann Bobbi Jo
- Relationship
-
VP of Sales and Marketing, Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ICCC
transaction
Derivative
Incentive Stock Options (Right to buy)
Award
- Transaction value
- Shares
- +5,000
- Change %
- Price
-
$0.000000*
- Shares after
- 5,000
- Date
- 16 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $5.49
* marks a reported price that did not pass the local price check.
SEC remarks
The options were granted by the Issuer to compensate directors for services on the Issuer's board of directors.